LEADER 01432nam  2200493Ia 450 
001 9910791822803321
005 20230721012832.0
010   $a1-61209-819-3
035   $a(CKB)2560000000070409
035   $a(EBL)3018959
035   $a(SSID)ssj0000466877
035   $a(PQKBManifestationID)11293082
035   $a(PQKBTitleCode)TC0000466877
035   $a(PQKBWorkID)10484742
035   $a(PQKB)11206155
035   $a(MiAaPQ)EBC3018959
035   $a(Au-PeEL)EBL3018959
035   $a(CaPaEBR)ebr10662765
035   $a(OCoLC)704300391
035   $a(EXLCZ)992560000000070409
100   $a20080807d2008      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAmbiol as base of new effective drugs$b[electronic resource] /$fYury V. Kuznetsov
210   $aNew York $cNova Science Publishers$dc2008
215   $a1 online resource (59 p.)
300   $aIncludes index.
311   $a1-60692-006-5 
606   $aEthephon$xTherapeutic use
606   $aAntioxidants$xTherapeutic use
615  0$aEthephon$xTherapeutic use.
615  0$aAntioxidants$xTherapeutic use.
676   $a613.2/8
700   $aKuznetsov$b Yury V$01478446
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910791822803321
996   $aAmbiol as base of new effective drugs$93694121
997   $aUNINA